Advertisement

Drugs & Therapy Perspectives

, Volume 16, Issue 6, pp 13–16 | Cite as

Health-related QOL measurements: key to optimal management of prostate cancer

Drug economics and quality of life
  • 13 Downloads

Keywords

Prostate Cancer Adis International Limited Sexual Dysfunction Goserelin Bicalutamide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sommers SD, Ramsey SD. A review of quality-of-life evaluations in prostate cancer. Pharmacoeconomics 1999; 16 (2): 127–40PubMedCrossRefGoogle Scholar
  2. 2.
    American Cancer Society. Cancer facts and figures: 1997. Atlanta (GA): American Cancer Society, 1997Google Scholar
  3. 3.
    Yarbro CH, Ferrans CE. Quality of life of patients with prostate cancer treated with surgery or radiation therapy. Oncol Nurs Forum 1998; 25 (4): 685–93PubMedGoogle Scholar
  4. 4.
    Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273 (2): 129–35PubMedCrossRefGoogle Scholar
  5. 5.
    Braslis KG, Santa CC, Brickman AL, et al. Quality of life 12 months after radical prostatectomy. Br J Urol 1995; 75 (1): 48–53PubMedCrossRefGoogle Scholar
  6. 6.
    Sall M, Madsen FA, Rhodes PR. Pelvic pain following radical retropubic prostatectomy: a prospective study. Urology 1997; 49 (4): 575–9PubMedCrossRefGoogle Scholar
  7. 7.
    Fowler FJJ, Barry MJ, Lu YG, et al. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 1995; 45 (6): 1007–13PubMedCrossRefGoogle Scholar
  8. 8.
    Beard CJ, Propert KJ, Rieker PP, et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 1997; 15 (1): 223–9PubMedGoogle Scholar
  9. 9.
    Fowler FJJ Barry MJ, Lu YG, et al. Outcomes of external-beam radiation therapy for prostate cancer: a study of medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 1996; 14 (8): 2258–65PubMedGoogle Scholar
  10. 10.
    Herr HW. Quality of life in prostate cancer patients. CA Cancer J Clin 1997; 47 (4): 207–17PubMedCrossRefGoogle Scholar
  11. 11.
    Herr HW, Kornblith AB, Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 1993; 71 (3 Suppl.): 1143–50PubMedCrossRefGoogle Scholar
  12. 12.
    Cassileth BR, Soloway MS, Vogelzang NJ, Zoladex Prostate Cancer Study Group, et al. Quality of life and psychosocial status in stage D prostate cancer. Qual Life Res 1992; 1 (5): 323–9PubMedCrossRefGoogle Scholar
  13. 13.
    Lucas MD, Strijdom SC, Berk M. Quality of life, sexual functioning and sex role identity after surgical orchidectomy in patients with prostatic cancer. Scand J Urol Nephrol 1995; 29 (4): 497–500PubMedCrossRefGoogle Scholar
  14. 14.
    Moore MJ, Osoba D, Murphy K, et al. Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. J Clin Oncol 1994; 12 (4): 689–94PubMedGoogle Scholar

Copyright information

© Adis International Limited 2000

Personalised recommendations